ABOUT THIS EPISODE
00:00 – Intro: AI-Designed Viruses and the Stanford Breakthrough02:10 – The Dual-Use Dilemma & Biosecurity Frontiers04:15 – Recreating Pathogens: Horse Pox & Smallpox Precedents06:25 – Anthropic Report: AI Exploits and Bioweapon Risks08:38 – Gain of Function, Geopolitics, and Asymmetric Threats11:35 – Interview Begins: Kevin Esvelt on CRISPR Gene Drives14:00 – The Inventor's Dilemma & Countering Gene Drives17:10 – Eradicating Malaria vs. Regulatory Challenges19:07 – Analyzing the Stanford Bacteriophage Experiment22:38 – The Threat of Limitless AI-Generated Pandemic Variants24:14 – Ordering 1918 Flu DNA: Testing Gene Synthesis Screening30:26 – Regulatory Loopholes in Select Agent Screening33:35 – Legislative Solutions & DNA Fragment Oversight35:50 – Designing Competent Bioweapons vs. Natural Pathogens38:28 – State Actors, Biopreparat, and "Dead Hand" Switches42:30 – Targeted Pathogens & The Probability of AI/Bio Catastrophe (p(doom))47:20 – Biodefense Solutions: PPE, Hadrien Project, and Critical Infrastructure51:24 – Far-UVC Lighting & Glycol Misting to End Airborne Disease57:42 – Closing Thoughts & Where to Find Kevin Esvelt's Work
